Histiocytic Sarcoma (HS)
Showing 1 - 25 of 1,734
Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston
Active, not recruiting
- Langerhans Cell Histiocytosis (LCH)
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 26, 2022
Histiocytic Disorder Follow-up Study
Recruiting
- Histiocytosis
- +5 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 13, 2023
Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
- Pharmacokinetic Study
- Ulixertinib
-
Birmingham, Alabama
- +108 more
Oct 19, 2022
Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)
Unknown status
- Sarcoma
- +16 more
- Sequential chemotherapy - 3 courses of AI
- Hypofractionated radiotherapy
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 19, 2021
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +118 more
Jan 27, 2023
Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +37 more
-
Birmingham, Alabama
- +171 more
Aug 24, 2022
Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto
Recruiting
- Malignant Solid Neoplasm
- +26 more
- Ensartinib
- +2 more
-
Birmingham, Alabama
- +121 more
Aug 24, 2022
Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +30 more
- Larotrectinib Sulfate
-
Birmingham, Alabama
- +123 more
Aug 23, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +32 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +124 more
Aug 24, 2022
Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States
Recruiting
- Malignant Solid Neoplasm
- +40 more
- Biospecimen Collection
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 27, 2023
Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
-
Birmingham, Alabama
- +113 more
Jun 28, 2022
Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)
Recruiting
- Sarcoma,Soft Tissue
- Selinexor 20 MG
- Gemcitabine
-
Tenerife, Canarias, Spain
- +10 more
Oct 27, 2023
Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG), Rosai-Dorfman Disease (RDD) Trial (Mirdametinib)
Not yet recruiting
- Langerhans Cell Histiocytosis (LCH)
- +3 more
- (no location specified)
Nov 22, 2023
Sarcoma, Soft Tissue Trial in Orange (Pembrolizumab, Stereotactic body radiation therapy)
Recruiting
- Sarcoma, Soft Tissue
- Pembrolizumab
- Stereotactic body radiation therapy
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 9, 2022
s to Diagnose Acute Myocardial Infarction in Elevated Hs-cTnT
Completed
- Acute Myocardial Infarction
- No Intervention
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 26, 2023
Switching From Cardiac Troponin I to T
Recruiting
- Acute Coronary Syndrome
- +5 more
- Clinical implementation of hs-cTnT
-
Edinburgh, United KingdomCentre for Cardiovascular Science
Feb 17, 2023
Hidradenitis Suppurativa, Acne Inversa Trial (Nd:YAG laser hair removal, Clindamycin 1 % Topical Lotion)
Not yet recruiting
- Hidradenitis Suppurativa, Acne Inversa
- Nd:YAG laser hair removal
- Clindamycin 1 % Topical Lotion
- (no location specified)
Feb 28, 2023
Nutritional Status on Oncologic and Operative Outcome in
Recruiting
- Retroperitoneal Sarcoma
- +5 more
- Measurement of body composition with computed tomography (CT)
- +5 more
-
Ljubljana, SloveniaInstitute of Oncology Ljubljana
Dec 2, 2022